A South Korean lettuce variety called heukharang or black harang, which serves as a natural treatment for insomnia is set for cultivation in Australia.
Jeollanamdo Agricultural Research & Extension Services (JARES) developed heukharang, which contains 3.74 milligrams of sleep-inducing lactucin per gram, or 124 times more than regular lettuce.
As the lactucin in regular lettuce is not potent enough to counter insomnia, an adult weighing 60 kilograms would need to consume 4 kilograms of it to induce sleep.
Heukharang would require much less consumption to achieve the desired results.
According to JARES, the Korean chemical firm Isu Chemical Co. has agreed to produce and sell heukharang lettuce in Australia.
Since Australia has strict quarantine laws for imported food but allows the importation of seeds, Isu Chemical Co. has to cultivate heukharang in Australia.
With its high gross national income and high prevalence of adult sleep disorders., Australia is a promising market for high-value-added and functional vegetables like heukharang.
Meanwhile. South Korea's market for insomnia treatment was estimated to be worth 40 billion won in 2020 and has been expanding at more than 5 percent annually.


Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
The Beauty Beneath the Expressway: A Journey from Self to Service
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
European Stocks Rise as Markets Await Key U.S. Inflation Data
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
Netflix’s Bid for Warner Bros Discovery Aims to Cut Streaming Costs and Reshape the Industry
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
The American mass exodus to Canada amid Trump 2.0 has yet to materialize
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback 



